Evaluation of downsized homograft conduits for right ventricle–to–pulmonary artery reconstruction  by McMullan, David Michael et al.
E
v
D
Y
Surgery for Congenital Heart Disease McMullan et al
6
CH
Dvaluation of downsized homograft conduits for right
entricle–to–pulmonary artery reconstruction
avid Michael McMullan, MD,a Guido Oppido, MD,a Nelson Alphonso, MD,a Andrew Donald Cochrane, MD,a,bves d’Udekem d’Acoz, MD,a,b and Christian P. Brizard, MDa,b
O
v
h
p
p
M
s
e
R
s
d
2
s
i
w
i
c
c
5
C
a
w
R
c
p
c
x
f
(
i
O
s
p
r
s
dFrom the Cardiac Surgery Unit, The Royal
Children’s Hospital,a and the Department
of Pediatrics, The University of Mel-
bourne,b Melbourne, Victoria, Australia.
Received for publication June 2, 2005; re-
visions received Jan 3, 2006; accepted for
publication Feb 17, 2006.
Address for reprints: Christian Pierre Robert
Brizard, MD, Cardiac Surgery Unit, The
Royal Children’s Hospital, Flemington Rd,
Parkville, Victoria, 3052, Australia (E-mail:
christian.brizard@rch.org.au).
J Thorac Cardiovasc Surg 2006;132:66-71
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgeryt
doi:10.1016/j.jtcvs.2006.02.041
6 The Journal of Thoracic and Cardiovbjective: Although homograft conduits are frequently used to establish right
entricle–to–pulmonary artery continuity, the limited availability of small-size
omografts is a significant constraint in pediatric cardiac surgery. We compared the
erformance of standard homograft conduits with that of surgically reduced bicus-
id homograft conduits in patients undergoing repair of truncus arteriosus.
ethods: Forty infants undergoing complete repair of truncus arteriosus with either
tandard homografts (n  26) or reduced-size bicuspid homografts (n  14) were
valuated.
esults: The median downsized conduit diameter (13 mm) was similar to the
tandard homograft diameter (12 mm, P .52). There were 6 early deaths and 5 late
eaths, representing an overall 30-day mortality of 15% and a 5-year mortality of
5%. No deaths were directly related to homograft dysfunction. Four (29%) down-
ized conduits and 8 (31%) standard conduits required replacement at a median
nterval of 18.5 months and 42.4 months, respectively. Catheter-based interventions
ere required in 5 (36%) patients in the downsized group and in 3 (12%) patients
n the standard group. There was no difference in freedom from surgical or
atheter-based reintervention between the 2 groups (P  .42). Freedom from
onduit failure (severe conduit stenosis, moderate or greater regurgitation) was
5.9% and 17.2% at 3 years in the downsized and standard groups, respectively.
onclusion: The surgically downsized homograft is an excellent option when an
ppropriate-sized homograft is not available and might prevent morbidity associated
ith the use of an oversized conduit.
econstruction of the right ventricular outflow tract in patients with congen-
ital heart disease frequently requires creation of a right ventricle (RV)–to–
pulmonary artery (PA) conduit to establish continuity of the pulmonary
irculation. Several types of valved conduits have been used successfully for this
urpose, including aortic and pulmonary homografts,1-3 composite bioprosthetic
onduits,4 xenografts,5 autologous pericardial valved conduits,6 and valved venous
enografts.7 Although homografts are generally preferred because they have greater
reedom from reintervention and are technically easier to sew than composite
Dacron) valved conduits,8 the shortage of small-size homografts remains a signif-
cant limitation. The use of surgically downsized homografts has been described.9-12
ne report has suggested early and midterm functional equivalency between down-
ized and nondownsized homografts.13 However, the study also describes a dispro-
ortionately high number of early deaths in the downsized group, which might
eflect disparate patient populations with respect to underlying anatomic defects and
urgical indications. In the current study we retrospectively compared the use of
ownsized homografts and standard homografts for RV-PA reconstruction in pa-
ients undergoing repair of truncus arteriosus.
ascular Surgery ● July 2006
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Dethods
etween 1995 and 2004, 40 consecutive children received a cryo-
reserved homograft conduit for RV-PA reconstruction during
omplete surgical correction of truncus arteriosus. Fourteen of
hese patients (median age, 56 days; range, 17-161 days) received
surgically downsized aortic (n  8) or pulmonary (n  6)
onduit because of the unavailability of an appropriately sized
omograft. The remaining 26 patients (median age, 46 days; range,
-673 days) received a standard aortic (n 12) or pulmonary (n
4) homograft conduit. Four (29%) patients in the downsized
roup and 6 (23%) patients in the standard group were less than 30
ays of age at the time of the operation. Three patients in the
tandard group had coexisting interrupted aortic arch or severe
oarctation and underwent concomitant arch reconstruction.
All patients underwent transthoracic echocardiographic exam-
nation before discharge from the hospital. Subsequent echocardi-
graphy was performed during routine clinical visits and if a
hange in symptoms, physical findings, or clinical status was
bserved. Study end points included mortality, freedom from
onduit replacement or reintervention, and freedom from clinically
ignificant conduit stenosis or insufficiency (severe stenosis or
oderate or greater insufficiency).
In this study conduit replacement was defined by surgical
eplacement of the conduit with another conduit. Catheter inter-
ention was defined by balloon dilation of conduit stenosis with or
ithout stenting. This study was done within the guidelines estab-
ished by our institutional human research ethics committee.
perative Technique
ll patients underwent complete surgical correction as the initial
rocedure. Surgical correction was performed on full-flow cardio-
ulmonary bypass by using intermittent antegrade cold blood
ardioplegia. In patients with type I or II truncus, the PA was
ivided close to the common arterial trunk, and the resultant
runcal defect was closed directly. When the PAs arose separately,
he common trunk was completely transected. The PAs were then
eparated proximally, and the truncal root was reconstructed by
sing an end-to-end anastomosis. A longitudinal ventriculotomy
as performed along the anterior surface of the right ventricular
utflow tract to the base of the common trunk. The ventricular
eptal defect was closed with a patch of autologous pericardium
reated with glutaraldehyde. When present, atrial septal defects
ere closed primarily. In patients with type I truncus, the common
A was anastomosed directly to the distal end of the conduit with
unning polypropylene sutures. When the PAs arose separately,
hey were prepared by performing a partial (one-third circumfer-
nce) anastomosis to each other before direct anastomosis to the
Abbreviations and Acronyms
CI  confidence interval
ECMO extracorporeal membrane oxygenation
PA  pulmonary artery
RV  right ventricle
Vmax maximum velocityistal end of the conduit. Proximal branch pulmonary arterioplasty s
The Journal of Thoracas performed when small-branch PAs were encountered. The
hoice of aortic versus pulmonary homografts was based solely on
vailability. However, a pulmonary homograft was preferentially
elected when both were available. The distribution of standard
nd downsized techniques used over the course of the study is
eported in Table 1.
Homografts were trimmed at the commissural level to facilitate
lacement of the valve as close as possible to the PA bifurcation
nd to prevent conduit valve compression or distortion by the
ternum. The RV-PA conduit was anastomosed to the RV by using
lutaraldehyde-treated pericardium or Gore-Tex for the construc-
ion of an anterior hood. The patient was then separated from
ardiopulmonary bypass support, and the chest was closed.
ethod of Homograft Downsizing
ryopreserved homografts were downsized according to the tech-
ique described by Michler and colleagues.9 After trimming the
omograft to the appropriate length, 2 parallel longitudinal inci-
ions were made through the valve annulus along the longitudinal
xis of the homograft. The incisions were oriented to preserve each
f the 3 commissures and 2 leaflets (Figure 1, A). The homograft
as then fashioned into a tube again, and a neocommissure was
onstructed by closing the longitudinal defect with running
olypropylene sutures (Figure 1, B). After downsizing, the new
ffective conduit diameter is approximately two thirds the diam-
ter of the original homograft. In our series surgical downsizing
roduced a 31%  5% reduction in mean homograft diameter, as
ssessed with Hegar dilators.
iagnostic Studies
ll patients were evaluated by means of transthoracic echocardiog-
aphy during the early postoperative period and before hospital dis-
harge. Patients were followed with routine transthoracic echocardio-
rams on an annual or semiannual basis. Interval echocardiographic
xaminations were performed for new symptoms or new findings on
hysical examination. For the purpose of this study, conduit insuffi-
iency was classified as trivial, mild, moderate, or severe. Conduit
tenosis was defined as mild (peak pressure gradient, 16-30 mm Hg;
aximum velocity [Vmax], 2-2.7 m/s), moderate (peak pressure
radient, 30-50 mm Hg; Vmax, 2.8-3.5 m/s), and severe (peak pres-
ABLE 1. Conduit use over time
Year Downsized Standard
1995 0 2
1996 2 3
1997 5 3
1998 0 6
1999 1 0
2000 0 4
2001 1 1
2002 4 2
2003 0 2
2004 1 3
Total 14 26ure gradient, 50 mm Hg; Vmax, 3.5 m/s).
ic and Cardiovascular Surgery ● Volume 132, Number 1 67
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DCardiac catheterization was performed when clinically signif-
cant conduit or branch PA stenosis was suggested by echocardi-
graphy. A conduit failure event was defined by the onset of severe
tenosis, moderate or greater regurgitation, or both. Conduit re-
lacement was performed only when severe conduit stenosis was
resent. Balloon angioplasty with or without endovascular stenting
as performed when stenotic lesions appeared amenable to trans-
atheter intervention.
tatistical Methods
nless otherwise specified, data are expressed as median group
alues. Statistical analysis was performed with Stata Version 8
oftware (StataCorp LP, College Station, Tex). Groups were com-
ared by using unpaired t tests. Survival analysis was performed
y using the Kaplan-Meier method, and comparison of survival
urves was performed by using the log-rank method.
esults
he patients in the downsized and standard groups were sim-
lar with respect to median body surface area, age at operation,
nd median implanted conduit diameter. The downsized group
f patients had a slightly greater weight at the time of the
peration (Table 2). In the downsized group the median ho-
ograft diameter was 19 mm (range, 15-21 mm) before down-
Figure 1. The technique used to downsize aortic homo
(a). Note that all 3 commissures are preserved after tri
technique for pulmonary homograft downsizing is idenizing and 13 mm (range, 10-16 mm) after downsizing. 9
8 The Journal of Thoracic and Cardiovascular Surgery ● July 2There were 6 early deaths in this series, representing an
verall 30-day mortality of 15%. One patient in the down-
ized group died at 20 days of progressive respiratory fail-
re and inability to wean from extracorporeal membrane
xygenation (ECMO) after intraoperative intrapulmonary
emorrhage. Five early deaths in the standard group oc-
urred at 1 day (dysrhythmia), 1 day (dysrhythmia), 4 days
withdrawal of ECMO support that was instituted for ven-
ricular failure and acidosis), 12 days (cardiovascular col-
apse caused by septic meningitis), and 13 days (withdrawal
f ECMO support that was instituted at the time of repair).
Median patient follow-up for the series was 66.4 months
range, 24 days to 9.6 years). Follow-up survival and rein-
ervention data were complete for all patients. During a
edian follow-up of 61.9 months (range, 9.5 months to 8.5
ears), there was one additional death in the downsized group.
he patient died at 33 days of sepsis. Actuarial survival in the
ownsized group was 84% (confidence interval [CI], 51%-
6%) at 5 years. During a median follow-up of 74.3 months
range, 24 days to 9.6 years), there were 4 additional deaths
n the standard group. These patients died at 59 days (septic
hock), 62 days (respiratory arrest caused by bronchiolitis),
s. Homograft trimming is represented by dashed lines
g. The completed homograft is also depicted (b). The
.graft
mmin
tical1 days (pulmonary hypertensive crisis and dysrhythmia),
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Dnd 114 days (unknown cause of death at home). Actuarial
urvival in the standard group was 70% (CI, 47%-84%) at 5
ears. There was no survival difference between the 2
roups (P  .35). No deaths in this series appeared to be
irectly related to homograft dysfunction. All surviving
atients were in New York Heart Association class I at the
atest follow-up.
onduit Replacement or Catheter Intervention
ourteen (35%) patients required conduit replacement or
atheter intervention in this series after a median interval of
8.1 months (range, 7 days to 7.2 years), representing an
verall freedom from conduit replacement or catheter inter-
ention of 47% (CI, 25%-69%) at 5 years (Figure 2). Four
29%) downsized conduits required replacement at a me-
ian interval of 18.5 months (range, 7 days to 45 months)
fter implantation. One of these was replaced on the seventh
ostoperative day because of the concern that extreme con-
uit dilation, caused by severe suprasystemic pulmonary
ypertension, was distorting the branch PAs. At the time of
he operation, the ventricular septal defect patch was fenes-
rated, and the 14-mm downsized conduit was replaced with
10-mm standard pulmonary homograft. All other conduits
ere replaced because of severe conduit stenosis. The me-
ian interval for conduit replacement caused by conduit
tenosis in the downsized group was 27.2 months (range,
.7-45 months). Eight (31%) standard conduits required
eplacement at a median interval of 42.4 months (range,
1.2-98.3 months) after implantation.
Catheter interventions were required in 5 (36%) patients
n the downsized group. Three patients underwent balloon
ilation with or without stenting of one or both branch PAs
t 3.8, 4.5, and 11.3 months, respectively. Balloon dilation
f severe conduit stenosis was required in 2 patients at 39.7
nd 51.3 months, respectively. One of these patients un-
erwent balloon dilation of the conduit and branch PAs.
atheter-based interventions were required in 3 (12%) pa-
ients in the standard group. No patients in the standard
roup required early surgical intervention. Three patients
nderwent balloon dilation with or without stenting for
evere conduit stenosis at 6.6, 12.6, and 24.1 months, re-
ABLE 2. Patient characteristics
Standard group
(n  26)
Downsized group
(n  14)
P
value
ody surface area (m2) 0.21 0.21 .15
ge (d) 46.0 55.5 .48
eight (kg) 3.5 4.1 .05
onduit diameter (mm) 12 13 .52
ndexed to body surface
area (mm/m2)
56 54 .48pectively. There was no difference in freedom from surgi- s
The Journal of Thoracal or catheter-based reintervention between the 2 groups, as
etermined by using the log-rank test for equality (P  .42,
igure 2).
One patient required surgical revision on the first post-
perative day to correct critical narrowing at the distal
nastomosis. This intervention was not included in the sta-
istical analysis.
onduit Function
t the latest follow-up (median, 61.9 months; range, 9.5-
01.8 months), 8 (57%) patients in the downsized group
ave not required conduit replacement. One of these pa-
ients has severe conduit stenosis, 6 have moderate conduit
tenosis, and 1 is free of conduit stenosis. Conduit regurgi-
ation is severe in 1, moderate in 3, and mild or trace in 4
atients. Freedom from severe conduit stenosis or moderate-
evere regurgitation was 55.9% (CI, 25.9%-85.9%) at 3
ears (Figure 3). At the latest follow-up (median, 47.3
onths; range, 0.8-115.2 months), 9 (35%) patients in the
tandard group have not required conduit replacement. One
f these patients has severe conduit stenosis, 5 have mod-
rate conduit stenosis, 1 has mild conduit stenosis, and 2 are
ree of conduit stenosis. Conduit regurgitation is severe in 1,
oderate in 2, mild or trace in 2, and absent in 4 patients in the
tandard group. Freedom from severe conduit stenosis or mod-
rate or severe regurgitation was 17.2% (CI, 0%-38.1%) at 3
ears, which is not statistically different than that observed in
he downsized group (P  .058, Figure 3).
For both the downsized and standard groups, the aortic
nd pulmonary homografts demonstrated comparable prob-
bility of freedom from failure (P  .31 and P  .45,
espectively).
iscussion
eplacement or reconstruction of the RV-PA outflow tract is
erformed frequently as part of complex surgical repairs for
igure 2. Kaplan-Meier freedom from conduit replacement or
atheter-based intervention in standard and downsized ho-
ograft conduits.evere congenital heart defects. The ideal surgical RV-PA
ic and Cardiovascular Surgery ● Volume 132, Number 1 69
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Donduit would provide long-term unobstructed forward flow
nd valve competency. Most currently available conduits, in-
luding homografts,1-3 composite bioprosthetic conduits,4 pul-
onary xenografts,5 autologous pericardial valved conduits,6
nd valved venous xenografts,7 provide excellent initial valve
ompetency and flow characteristics. However, progressive
onduit stenosis and valve dysfunction often develop over
ime, necessitating early conduit replacement.
In general, composite xenograft conduits are more prone
o calcification and early failure than homografts, with sig-
ificant right ventricular outflow tract obstruction occurring
n up to 77% of patients within 12 months of xenograft
mplantation in patients younger than 1 year.14 Actuarial
reedom from reintervention after implantation ranges from
8% at 18 months4 to 64% at 4 years,15 depending on the
ype of conduit used. Limited stentless xenograft root con-
uit durability has also been reported,5 and stentless con-
uits are not available in small sizes.
In most institutions aortic and pulmonary homografts are
he preferred conduits used for RV-PA reconstruction because
hey offer improved valve durability and are technically easier
o sew than composite (Dacron) valved conduits.8 The longev-
ty of homograft conduits varies widely, with reported freedom
rom homograft replacement ranging from approximately 50%
t 3 years2 to approximately 75% at 10 years.1 Conduit ste-
osis remains the most common indication for reinterven-
ion.16 Limited availability of small-size homografts is a
ignificant constraint to their use as conduits, and the trend
oward earlier surgical intervention across the spectrum of
ardiac defects might further limit the availability of appro-
riately sized homografts.
Michler and colleagues9 initially reported a technique for
urgically downsizing homograft conduits by excising one
eaflet. Subsequently, several groups have reported limited
igure 3. Kaplan-Meier freedom from failure events (severe ste-
osis, moderate or greater insufficiency) in standard and down-
ized homograft conduits.linical experience with similar techniques to reconstruct y
0 The Journal of Thoracic and Cardiovascular Surgery ● July 2he right ventricular outflow tract.10-12 Although downsized
omograft conduits exhibit excellent initial valve compe-
ence and flow characteristics in vitro,17 their long-term
linical performance has not been well defined. Koirala and
ssociates13 recently described their experience with down-
ized homograft conduits. In their series they reported that
ownsized homografts exhibit early and midterm valve
unction that is similar to that seen with standard ho-
ografts. However, the retrospective study also reports a
isproportionately high number of early deaths (38%) in the
roup undergoing downsized conduit placement, which
ight reflect disparate patient populations with respect to
nderlying anatomic defects and surgical indications.
In the current study we compared the use of downsized
omografts and standard homografts for RV-PA reconstruc-
ion exclusively in patients undergoing repair of truncus
rteriosus to exclude differences in underlying anatomy and
athophysiologic complexity. There were 6 hospital deaths
n our series, representing a 30-day mortality of 15%. No
eaths appeared to be directly related to homograft dysfunc-
ion. In all cases the decision to use a downsized conduit
as based solely on the lack of availability of an appropri-
tely sized homograft.
Small conduit diameter has been described as a risk
actor for early conduit failure in young patients.18 In our
eries the measured and normalized diameters of downsized
omografts were similar to those in the nondownsized
roup. Although oversized homografts can be used as
V-PA conduits,12 limited space within the mediastinal
avity might preclude their use in many patients. We believe
hat one early death in our series is attributable to the use of
disproportionately large nondownsized conduit. In this
ase a 17-mm (70.3 mm/m2) conduit was used in a 4.0-kg
atient. The patient was hemodynamically stable in the
arly postoperative period but experienced hypotension and
ardiac arrest shortly after delayed sternal closure. Postmor-
em review suggested right ventricular compression by the
omograft. In the case of the patient in whom a downsized
onduit was replaced at 7 days, we believe that fixed severe
ulmonary hypertension contributed to dilation of the ho-
ograft, which produced branch PA distortion.
Patients who received a downsized homograft in this
eries had a 44.7% predicted freedom from severe conduit
tenosis or moderate or severe regurgitation at 5 years
ompared with 8.6% in the standard group (Figure 3).
urthermore, in both the standard and downsized groups, no
ifferences between aortic and pulmonary homografts were
bserved.
These results are somewhat better than those reported for
ondownsized homografts in infants, in which freedom
rom allograft dysfunction ranges from 37%19 to 54%2 at 2
ears. Moreover, freedom from allograft dysfunction is
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Dloser to 80% at 2 years when larger (12-15 mm) ho-
ografts are used.2
In this series the overall freedom from surgical or catheter-
ased reintervention was the same for patients receiving
ither downsized or standard homografts for RV-PA recon-
truction during repair of truncus arteriosus. No difference
n downsized or standard conduit performance or longevity
as observed in this study, irrespective of whether an aortic
r pulmonary homograft was used.
In conclusion, we believe that the surgically downsized
omograft is an excellent option when an appropriately
ized homograft is not available and might prevent morbid-
ty associated with the use of an oversized conduit.
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